Supplementation with a novel emulsion composition comprising prostaglandin E1 (lipid/PGE1) (a gift from TAIWAN LIPOSOME COMPANY) in rats with monocrotaline-induced PAH prevented pulmonary arterial remodeling and improved hemodynamics by inducing PTEN expression. Here, PTEN is linked to pulmonary arterial hypertension.